COVID-19, Hospital and Myocardial Infarction

Increased Risk of Heart Rhythm Disruption After COVID-19

DAIC

DECEMBER 14, 2023

Ioannis Katsoularis, image courtesy of Klas Sjöberg milla1cf Thu, 12/14/2023 - 09:23 December 14, 2023 — Individuals infected with COVID-19 are also at an increased risk of suffering from heart rhythm disturbances, such as atrial fibrillation. We could also see that unvaccinated people were at higher risk than vaccinated people.

COVID-19

COVID-19 Heart Rhythm Atrial Fibrillation Tachycardia

Prevalence and effects of acute myocardial infarction on hospital outcomes among COVID-19 patients

Coronary Artery Disease Journal

OCTOBER 23, 2023

Background Acute myocardial infarction (AMI) is one of the most lethal complications of COVID-19 hospitalization. In this study, we looked for the occurrence of AMI and its effects on hospital outcomes among COVID-19 patients. Prolonged LOS was defined as any hospital LOS ≥ 75th percentile.

COVID-19

COVID-19 Myocardial Infarction Hospital ICU

The impact of COVID-19 and the COVID-19 pandemic on hospitalized patients with STEMI in the United States: insights from the National Inpatient Sample

Coronary Artery Disease Journal

OCTOBER 31, 2023

Background It is unclear how COVID-19 pandemic affected care and outcomes among patients who are diagnosed with ST-elevation myocardial infarction (STEMI) in the USA. Results There were 1 050 905 hospitalizations with STEMI, and there was an 8.2% 12.55, P < 0.001) with COVID-19 infection compared with no infection.

COVID-19

COVID-19 STEMI Inpatient Hospital

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Impact of the COVID-19 pandemic on acute coronary syndrome hospital admission and management in Slovenia

Open Heart

NOVEMBER 20, 2023

Aims We evaluated the effects of the COVID-19 pandemic on hospital admission and quality of care for acute coronary syndrome. Data on 21 001 patients were included (7057 ST-elevation myocardial infarction (STEMI), 7649 non-ST elevation myocardial infarction (NSTEMI) and 6295 unstable angina).

COVID-19

COVID-19 Hospital Angina Myocardial Infarction

COVID-19 myocarditis illusions

Dr. Anish Koka

FEBRUARY 6, 2023

I’m a cardiologist, and the first disconnect that became glaringly obvious very quickly was the impact COVID was having on the heart. As I walked through COVID rooms in the Spring of 2020 trying to hold my breath, I waited for a COVID cardiac tsunami. There never was a cardiac tsunami from COVID. But it got worse.

COVID-19

COVID-19 Chest Pain Academic Hospital

Impact of COVID-19 on Digital Cardiology Care

SoftCath

OCTOBER 31, 2021

Since the onset of COVID-19, cardiology care has been under extreme risk and adverse complications. For this reason, the management of cardiac patients in the hospital environment has proven to be a real, enormous challenge during and after the pandemic.

COVID-19

COVID-19 Innovation Cardiac Rehabilitation Cardiovascular Disease

New ECG Study Reveals Myocarditis Risk in Athletes after Covid-19.

Wellnest

JUNE 1, 2023

The World Health Organisation (WHO) formally proclaimed COVID-19, the illness spread by a zoonotic SARS-CoV-2, as a pandemic in March 2020, after it had started to spread in late 2019. And, addressing myocardial infarction, recent studies have shown that 1-4% of Athletes untimely die due to myocarditis caused by COVID-19.

COVID-19

COVID-19 Myocardial Infarction Thrombosis Electrocardiogram

Social Vulnerability and Long‐Term Cardiovascular Outcomes After COVID‐19 Hospitalization: An Analysis of the American Heart Association COVID‐19 Registry Linked With Medicare Claims Data

Journal of the American Heart Association

MARCH 21, 2025

BackgroundPatients hospitalized with COVID19 from socioeconomically vulnerable communities are at risk for inhospital cardiovascular events. ConclusionsAmong survivors of COVID19 hospitalization, patientlevel social vulnerability was associated with cardiovascular events, explained by increased comorbidities.

COVID-19

COVID-19 Medicare Cardiogenic Shock Hospital

Classification Algorithm to Distinguish Between Type 1 and Type 2 Myocardial Infarction in Administrative Claims Data

Circulation: Cardiovascular Quality & Outcomes

JANUARY 19, 2024

Background:Type 2 myocardial infarction (T2MI) and type 1 myocardial infarction (T1MI) differ with respect to demographics, comorbidities, treatments, and clinical outcomes. 3.48]), and diagnoses of COVID-19 (odds ratio, 1.74 [95% CI, 1.11–2.71]) T1MI and 53.5% T2MI; mean age, 79±10.3 years; 47% female).

Myocardial Infarction

Myocardial Infarction COVID-19 Medicare Hospital

Rationale and Design for the LOnger-term effects of SARS-CoV-2 INfection on blood Vessels And blood pRessure (LOCHINVAR): an observational phenotyping study

Open Heart

JUNE 24, 2022

Introduction COVID-19 may lead to long-term endothelial consequences including hypertension, stroke and myocardial infarction. mm Hg higher BP ≥12 weeks after recovery, compared with a group without COVID-19. mm Hg higher BP ≥12 weeks after recovery, compared with a group without COVID-19.

Blood Pressure

Blood Pressure COVID-19 Myocardial Infarction Hypertension

SGLT-2 Inhibitors Show Mixed Results After Heart Attack

DAIC

APRIL 6, 2024

However, researchers said the drug may be helpful in reducing heart failure risks, including hospitalization, following a heart attack. To have a 25% to 30% reduction in heart failure hospitalizations is pretty clinically meaningful, but if you put it together with all-cause mortality, it was not a positive study for our primary endpoint.”

Heart attacks

Heart attacks Heart Attack Heart Failure Outpatient

EMPACT-MI Trial Outcomes Reported at ACC24: SGLT-2 Inhibitors Show Mixed Results After Heart Attack

DAIC

APRIL 6, 2024

While composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack, according to results from the EMPACT-MI trial presented on day one of the American College of Cardiology Scientific Sessions, ACC.24, 24, being held in Atlanta, GA.

Heart attacks

Heart attacks Heart Attack Heart Failure Outcomes

Extreme shock and cardiac arrest in COVID patient

Dr. Smith's ECG Blog

NOVEMBER 12, 2020

This is a 30-something healthy patient presented with COVID pneumonia who presented to the ED. An elevated troponin in a COVID patient confers about 4x the risk of mortality than a normal one. Beware elevated troponins in COVID patients. He was moderately hypoxic. There is minimal, probably normal STE in V2-V6. 3–8 Shi et al.

Cardiac Arrest

Cardiac Arrest COVID-19 Myocardial Infarction Cardiogenic Shock

Very early invasive strategy in higher risk non-ST-elevation acute coronary syndrome: the RAPID NSTEMI trial

Heart BMJ

MARCH 12, 2024

The primary outcome was a composite of all-cause mortality, new myocardial infarction or hospitalisation for heart failure at 12 months. Results The trial was discontinued early by the funder due to slow recruitment during the COVID-19 pandemic. The length of hospital stay was reduced with a very early IS (3.9

COVID-19

COVID-19 Myocardial Infarction Heart Failure Outcomes

Cardiac events and procedures following COVID-19 compared with other pneumonias: a national register study

Open Heart

FEBRUARY 4, 2025

Background Studies have shown an increased risk of cardiac disease following COVID-19, but how it compares to pneumonia of other etiologies is unclear. Aims To determine the incidence and HRs of cardiac disease in patients hospitalised with COVID-19 compared with other viral or bacterial pneumonias.

COVID-19

COVID-19 Myocardial Infarction Atrial Fibrillation Heart Failure

Published Research

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The Society (..)

Research

Research Coronary Artery Bypass Graft Aortic valve Congenital

Published Research

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)

Research

Research Coronary Artery Bypass Graft Aortic valve Congenital

Cardiovascular Update

Increased Risk of Heart Rhythm Disruption After COVID-19

Prevalence and effects of acute myocardial infarction on hospital outcomes among COVID-19 patients

The impact of COVID-19 and the COVID-19 pandemic on hospitalized patients with STEMI in the United States: insights from the National Inpatient Sample

Webinars

Impact of the COVID-19 pandemic on acute coronary syndrome hospital admission and management in Slovenia

COVID-19 myocarditis illusions

Impact of COVID-19 on Digital Cardiology Care

New ECG Study Reveals Myocarditis Risk in Athletes after Covid-19.

Social Vulnerability and Long‐Term Cardiovascular Outcomes After COVID‐19 Hospitalization: An Analysis of the American Heart Association COVID‐19 Registry Linked With Medicare Claims Data

Classification Algorithm to Distinguish Between Type 1 and Type 2 Myocardial Infarction in Administrative Claims Data

Rationale and Design for the LOnger-term effects of SARS-CoV-2 INfection on blood Vessels And blood pRessure (LOCHINVAR): an observational phenotyping study

SGLT-2 Inhibitors Show Mixed Results After Heart Attack

EMPACT-MI Trial Outcomes Reported at ACC24: SGLT-2 Inhibitors Show Mixed Results After Heart Attack

Extreme shock and cardiac arrest in COVID patient

Very early invasive strategy in higher risk non-ST-elevation acute coronary syndrome: the RAPID NSTEMI trial

Cardiac events and procedures following COVID-19 compared with other pneumonias: a national register study

Published Research

Published Research

Stay Connected